News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
330,516 Results
Type
Article (19792)
Company Profile (139)
Press Release (310585)
Section
Business (106141)
Career Advice (866)
Deals (18643)
Drug Delivery (89)
Drug Development (50999)
Employer Resources (79)
FDA (7744)
Job Trends (7791)
News (187090)
Policy (17445)
Tag
Academia (768)
Alliances (27924)
Alzheimer's disease (579)
Approvals (7708)
Artificial intelligence (77)
Bankruptcy (173)
Best Places to Work (5545)
Biosimilars (68)
Biotechnology (61)
Cancer (495)
Cardiovascular disease (51)
Career advice (704)
Cell therapy (70)
Clinical research (41860)
Collaboration (180)
Compensation (64)
COVID-19 (1089)
C-suite (55)
Data (522)
Diabetes (89)
Diagnostics (1762)
Drug pricing (90)
Earnings (38340)
Employer resources (73)
Events (48074)
Executive appointments (167)
FDA (7980)
Funding (136)
Gene therapy (83)
GLP-1 (475)
Government (1830)
Healthcare (6044)
Infectious disease (1137)
Inflammatory bowel disease (67)
Interviews (114)
IPO (7341)
Job creations (2442)
Job search strategy (645)
Layoffs (250)
Legal (4106)
Lung cancer (91)
Manufacturing (115)
Medical device (2121)
Medtech (2124)
Mergers & acquisitions (11322)
Metabolic disorders (311)
Neuroscience (728)
NextGen Class of 2024 (2413)
Non-profit (985)
Northern California (593)
Obesity (204)
Opinion (173)
Patents (67)
People (33217)
Pharmaceutical (75)
Phase I (13050)
Phase II (17734)
Phase III (14259)
Pipeline (205)
Podcasts (54)
Policy (66)
Postmarket research (1612)
Preclinical (4594)
Radiopharmaceuticals (154)
Rare diseases (128)
Real estate (3195)
Regulatory (12185)
Research institute (859)
Resumes & cover letters (139)
Southern California (556)
Startups (2026)
United States (5588)
Vaccines (211)
Weight loss (179)
Date
Today (113)
Last 7 days (511)
Last 30 days (1621)
Last 365 days (18002)
2024 (15796)
2023 (19884)
2022 (26175)
2021 (26984)
2020 (25207)
2019 (20414)
2018 (15835)
2017 (17413)
2016 (16382)
2015 (19045)
2014 (14977)
2013 (12689)
2012 (13585)
2011 (13950)
2010 (12841)
Location
Africa (417)
Asia (24562)
Australia (3199)
California (1341)
Canada (701)
China (132)
Colorado (56)
Connecticut (52)
Europe (50712)
Florida (182)
Illinois (136)
Indiana (110)
Kansas (56)
Maryland (218)
Massachusetts (1152)
Minnesota (81)
New Jersey (523)
New York (399)
North Carolina (345)
Northern California (593)
Ohio (62)
Pennsylvania (339)
South America (608)
Southern California (556)
Texas (170)
Washington State (133)
330,516 Results for "leo pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Germany Becomes the First Country to Launch LEO Pharma’s Anzupgo® (delgocitinib) Cream
October 15, 2024
·
8 min read
Press Releases
LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China
September 27, 2024
·
6 min read
Press Releases
LEO Pharma Presents Adbry® (tralokinumab-ldrm) and Delgocitinib Cream Data at 2024 Fall Clinical Dermatology Conference
October 23, 2024
·
16 min read
Press Releases
FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema
September 23, 2024
·
10 min read
Press Releases
European Commission Approves LEO Pharma’s Anzupgo® (delgocitinib) Cream for Adults with Moderate to Severe Chronic Hand Eczema (CHE)
September 23, 2024
·
9 min read
Press Releases
LEO Pharma Presents Final Results of ECZTEND Long-Term Adbry® Trial (tralokinumab-ldrm) in Patients with Moderate-to-Severe Atopic Dermatitis (AD) at Fall Clinical 2024
October 25, 2024
·
10 min read
Pharm Country
LEO Pharma Presents Data at 2024 Winter Clinical and Maui Derm Conferences
LEO Pharma A/S, a global leader in medical dermatology, will present a catalog of investigational delgocitinib cream and Adbry® data across 10 posters at the upcoming Winter Clinical and Maui Derm conferences this month.
January 12, 2024
·
14 min read
News
LEO Pharma Presents Late-breaking Tralokinumab Data at EADV 2024 for Moderate-to-Severe Atopic Dermatitis (AD) in the Difficult-to-Treat Head and Neck Region
September 27, 2024
·
12 min read
News
LEO Pharma Presents Late-Breaking Anzupgo® (delgocitinib) Cream Presentation at EADV 2024 Highlighting Results of Head-to-Head DELTA FORCE Trial in Chronic Hand Eczema (CHE)
September 25, 2024
·
15 min read
Business
LEO Pharma Connects Affiliates with Veeva Vault Safety to Transform Safety Operations
Veeva Systems (NYSE: VEEV) today announced that LEO Pharma , a global leader in medical dermatology, is using Veeva Vault Safety to optimize its safety operations.
October 3, 2023
·
3 min read
1 of 33,052
Next
